Your browser doesn't support javascript.
loading
Phase III randomized intergroup trial of subtotal lymphoid irradiation versus doxorubicin, vinblastine, and subtotal lymphoid irradiation for stage IA to IIA Hodgkin's disease.
Press, O W; LeBlanc, M; Lichter, A S; Grogan, T M; Unger, J M; Wasserman, T H; Gaynor, E R; Peterson, B A; Miller, T P; Fisher, R I.
Affiliation
  • Press OW; Fred Hutchinson Cancer Research Center, Seattle, Washington, USA.
J Clin Oncol ; 19(22): 4238-44, 2001 Nov 15.
Article in En | MEDLINE | ID: mdl-11709567
Subject(s)
Search on Google
Add to My VHL
Print
XML
PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Hodgkin Disease / Antineoplastic Combined Chemotherapy Protocols / Lymphoid Tissue Type of study: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Aspects: Patient_preference Limits: Adolescent / Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: J Clin Oncol Year: 2001 Document type: Article Affiliation country: Country of publication:
Search on Google
Add to My VHL
Print
XML
PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Hodgkin Disease / Antineoplastic Combined Chemotherapy Protocols / Lymphoid Tissue Type of study: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Aspects: Patient_preference Limits: Adolescent / Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: J Clin Oncol Year: 2001 Document type: Article Affiliation country: Country of publication: